Skip to main content
SpringerLink
Log in

Endometrial Carcinoma: Epidemiology and Risk Factors

  • Chapter
  • First Online:
Preventive Oncology for the Gynecologist

Abstract

Endometrial cancer is one of the important cancers in women of developed countries, but its incidence in developing or underdeveloped countries is low. With the change in lifestyle and dietary habits, there is a change in trend of the disease in various countries. Most cases of endometrial cancers present at early stages and are generally associated with good prognosis; hence, mortality and morbidity are low. The commonest type of endometrial malignancy is endometrioid type (type I) which is predominantly estrogen dependent, and any condition leading to increase in estrogen whether endogenous or exogenous can lead to endometrial malignancy. In this chapter, we will be detailing the epidemiology of the disease as well as various risk factors that are causative for development of endometrial carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. https://doi.org/10.3322/caac.21387.

    Article  Google Scholar 

  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.

    Article  CAS  Google Scholar 

  3. Terri M, David S, Sherman AJ, Ann GS, Stephen BG. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am. J Public Health. 2014;94:2104–11.

    Google Scholar 

  4. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21. https://doi.org/10.1158/0008-5472.CAN-14-0155.

    Article  CAS  Google Scholar 

  5. Sheikh MA, Althouse AD, Freese KE, et al. USA endometrial cancer projections to 2030: should we be concerned? Future Oncol. 2014;10(16):2561–8. https://doi.org/10.2217/fon.14.192.

    Article  CAS  PubMed  Google Scholar 

  6. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27–43.

    Article  Google Scholar 

  7. Zeleniuch-Jacquotte A, Lundin E, et al. Circulating enterolactone and risk of endometrial cancer. Int J Cancer. 2006;119:2376–81.

    Article  CAS  Google Scholar 

  8. http://seer.cancer.gov/statfacts/html/corp.html. Accessed 28 Jan 2018

  9. Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012;118(9):2338–66. https://doi.org/10.1002/cncr.27514.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10.

    Article  CAS  Google Scholar 

  11. Felix AS, Weissfeld JL, Stone RA, et al. Factors associated with type I and type II endometrial cancer. Cancer Causes Control. 2010;21:1851.

    Article  Google Scholar 

  12. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45:277.

    Article  CAS  Google Scholar 

  13. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer. 2001;84:975.

    Article  CAS  Google Scholar 

  14. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–36.

    Article  Google Scholar 

  15. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569.

    Article  Google Scholar 

  16. Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol. 2005;193:1640.

    Article  Google Scholar 

  17. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. N Engl J Med. 2003;348:1625–38.

    Article  Google Scholar 

  18. Pillay OC, Te Fong LF, Crow JC, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod. 2006;21:924–9.

    Article  CAS  Google Scholar 

  19. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003;361:1810–2.

    Article  Google Scholar 

  20. Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 1992;167:1317.

    Article  CAS  Google Scholar 

  21. Xu WH, Xiang YB, Ruan ZX, et al. Menstrual and reproductive factors and endometrial cancer risk: results from a population-based case-control study in urban Shanghai. Int J Cancer. 2004;108:613.

    Article  CAS  Google Scholar 

  22. Karageorgi S, Hankinson SE, Kraft P, de Vivo I. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses’ Health Study cohort 1976–2004. Int J Cancer. 2010;126:208.

    Article  CAS  Google Scholar 

  23. Pettersson B, Adami HO, Bergstrom R, Johansson ED. Menstruation span ± a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynaecol Scand. 1986;65:247–55.

    Article  CAS  Google Scholar 

  24. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180.

    Article  Google Scholar 

  25. Lucenteforte E, Talamini R, Montella M, et al. Family history of cancer and the risk of endometrial cancer. Eur J Cancer Prev. 2009;18:95.

    Article  Google Scholar 

  26. Mucci LA, Hjelmborg JB, Harris JR, et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA. 2016;315:68.

    Article  CAS  Google Scholar 

  27. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32.

    Article  CAS  Google Scholar 

  28. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–10. J Med Genet 2013; 50, 255–263

    Article  CAS  Google Scholar 

  29. Hendriks YM, Wagner A, Morreau H, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology. 2004;127:17–25.

    Article  CAS  Google Scholar 

  30. Thompson D, Easton DF. Breast cancer linkage consortium. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst. 2002;94:1358.

    Article  CAS  Google Scholar 

  31. Beiner ME, Finch A, Rosen B, et al. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol Oncol. 2007;104:7.

    Article  CAS  Google Scholar 

  32. Hanssen AM, Fryns JP. Cowden syndrome. J Med Genet. 1995;32:117–9.

    Article  CAS  Google Scholar 

  33. Bubien V, Bonnet F, Brouste V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet. 2013;50:255–63.

    Article  CAS  Google Scholar 

  34. Heald B, Mester J, Rybicki L, et al. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology. 2010;139:1927.

    Article  CAS  Google Scholar 

  35. Riegert-Johnson DL, Gleeson FC, Roberts M, et al. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract. 2010;8:6.39: 1927

    Article  Google Scholar 

  36. Lim W, Hearle N, Shah B, et al. Further observations on LKB1/STK11 status and cancer risk in Peutz–Jeghers syndrome. Br J Cancer. 2003;89:308–13.

    Article  CAS  Google Scholar 

  37. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–53.

    Article  CAS  Google Scholar 

  38. Bandera EV, Kushi LH, Moore DF, et al. Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis. Cancer Causes Control. 2007;18:967.

    Article  Google Scholar 

  39. Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM. Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer. 2008;99:434.

    Article  CAS  Google Scholar 

  40. Loerbroks A, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control. 2007;18:551.

    Article  Google Scholar 

  41. Sun Q, Xu L, Zhou B, et al. Alcohol consumption and the risk of endometrial cancer: a meta-analysis. Asia Pac J Clin Nutr. 2011;20:125.

    PubMed  Google Scholar 

  42. Furness S, Roberts H, Marjoribanks J, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2009;2:CD000402.

    Google Scholar 

  43. Voigt LF, Weiss NS, Chu J, et al. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet. 1991;338:274.

    Article  CAS  Google Scholar 

  44. Persson I, Adami HO, Bergkvist L, et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ. 1989;298:147.

    Article  CAS  Google Scholar 

  45. Beral V, Bull D, Reeves G, Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005;365:1543.

    Article  Google Scholar 

  46. Anderson GL, Judd HL, Kaunitz AM, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s Health Initiative randomized trial. JAMA. 2003;290:1739.

    Article  CAS  Google Scholar 

  47. Iqbal J, Ginsburg OM, Wijeratne TD, et al. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev. 2012;38:318.

    Article  CAS  Google Scholar 

  48. Barakat RR, Wong G, Curtin JP, et al. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol. 1994;55:164.

    Article  CAS  Google Scholar 

  49. Committee Opinion No. 601: Tamoxifen and uterine cancer. Obstet Gynecol. 2014; 123:1394.

    Google Scholar 

  50. Horn-Ross PL, John EM, Canchola AJ, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst. 2003;95:1158.

    Article  CAS  Google Scholar 

  51. Myung SK, Ju W, Choi HJ, et al. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG. 2009;116:1697.

    Article  Google Scholar 

  52. North American Menopause Society. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause. 2011;18:732.

    Article  Google Scholar 

  53. Parazzini F, Negri E, La Vecchia C, et al. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer. 1998;76:784.

    Article  CAS  Google Scholar 

  54. Henderson BE, Casagrande JT, Pike MC, et al. The epidemiology of endometrial cancer in young women. Br J Cancer. 1983;47:749–56.

    Article  CAS  Google Scholar 

  55. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365.

    Article  CAS  Google Scholar 

  56. Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer. 2008;98:1582.

    Article  CAS  Google Scholar 

  57. Liang SX, Pearl M, Liang S, et al. Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger. Int J Cancer. 2011;128:763.

    Article  CAS  Google Scholar 

  58. Winer I, Lehman A, Wactawski-Wende J, et al. Tubal ligation and risk of endometrial cancer: findings from the Women’s Health Initiative. Int J Gynecol Cancer. 2016;26:464.

    Article  Google Scholar 

  59. Ayeni TA, Bakkum-Gamez JN, Mariani A, et al. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma. Gynecol Oncol. 2013;128:71.

    Article  Google Scholar 

  60. Elwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. Br J Hosp Med. 1997;59:1055–60.

    Google Scholar 

  61. Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol. 2015;16:1061.

    Article  Google Scholar 

  62. Iversen L, Sivasubramaniam S, Lee AJ, et al. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol. 2017;216:580.e1.

    Article  Google Scholar 

  63. Soini T, Hurskainen R, Grénman S, et al. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Obstet Gynecol. 2014;124:292.

    Article  CAS  Google Scholar 

  64. Montz FJ, Bristow RE, Bovicelli A, et al. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651.

    Article  CAS  Google Scholar 

  65. Setiawan VW, Pike MC, Karageorgi S, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol. 2012;176:269.

    Article  Google Scholar 

  66. Jordan SJ, Na R, Johnatty SE, et al. Breastfeeding and endometrial cancer risk: an analysis from the epidemiology of endometrial cancer consortium. Obstet Gynecol. 2017;129:1059.

    Article  Google Scholar 

  67. Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med. 2008;121:501.

    Article  CAS  Google Scholar 

  68. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr. 2002;132:3456S.

    Article  CAS  Google Scholar 

  69. Bravi F, Scotti L, Bosetti C, et al. Coffee drinking and endometrial cancer risk: a meta-analysis of observational studies. Am J Obstet Gynecol. 2009;200:130.

    Article  Google Scholar 

  70. Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res. 2011;55:931.

    Article  CAS  Google Scholar 

  71. McCullough ML, Bandera EV, Moore DF, Kushi LH. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med. 2008;46:298.

    Article  CAS  Google Scholar 

  72. Matsuo K, Cahoon SS, Yoshihara K, et al. Association of low-dose aspirin and survival of women with endometrial cancer. Obstet Gynecol. 2016;128:127.

    Article  CAS  Google Scholar 

  73. Podratz KC, Mariani A. Uterine papillary serous carcinomas: the exigency for clinical trials. Gynecol Oncol. 2003;91:461.

    Article  Google Scholar 

  74. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev. 2002;11:1531–43.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, ANIIMS, Port Blair, Andaman and Nicobar Islands, India

    Ritu Khatuja

  2. Department of Obstetrics and Gynaecology, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India

    Swati Rai

Authors
  1. Ritu Khatuja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Swati Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Babu Jagjivan Ram Memorial Hospital, New Delhi, India

    Sumita Mehta

  2. Department of Obstetrics and Gynecology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India

    Anshuja Singla

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Khatuja, R., Rai, S. (2019). Endometrial Carcinoma: Epidemiology and Risk Factors. In: Mehta, S., Singla, A. (eds) Preventive Oncology for the Gynecologist. Springer, Singapore. https://doi.org/10.1007/978-981-13-3438-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3438-2_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3437-5

  • Online ISBN: 978-981-13-3438-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation